Deucravacitinib, a TYK2 inhibitor, safety in psoriasis and psoriatic arthritis: What should a dermatologist know?
- Resource Type
- article
- Source
- JEADV Clinical Practice, Vol 2, Iss 2, Pp 382-385 (2023)
- Subject
Dermatology RL1-803 Diseases of the genitourinary system. Urology RC870-923 - Language
- English
- ISSN
- 2768-6566